Logo image of C5H.I

CAIRN HOMES PLC (C5H.I) Stock Fundamental Analysis

Europe - Euronext Dublin - DUB:C5H - IE00BWY4ZF18 - Common Stock

2.05 EUR
-0.03 (-1.44%)
Last: 1/2/2026, 7:00:00 PM
Fundamental Rating

6

Overall C5H gets a fundamental rating of 6 out of 10. We evaluated C5H against 32 industry peers in the Household Durables industry. While C5H has a great profitability rating, there are some minor concerns on its financial health. C5H has a correct valuation and a medium growth rate. C5H also has an excellent dividend rating. With these ratings, C5H could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year C5H was profitable.
In the past year C5H has reported a negative cash flow from operations.
In the past 5 years C5H has always been profitable.
Of the past 5 years C5H 4 years had a positive operating cash flow.
C5H.I Yearly Net Income VS EBIT VS OCF VS FCFC5H.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.73%, C5H belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
The Return On Equity of C5H (13.01%) is better than 81.25% of its industry peers.
The Return On Invested Capital of C5H (10.12%) is better than 84.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for C5H is in line with the industry average of 9.55%.
Industry RankSector Rank
ROA 7.73%
ROE 13.01%
ROIC 10.12%
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
C5H.I Yearly ROA, ROE, ROICC5H.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

C5H has a Profit Margin of 12.77%. This is amongst the best in the industry. C5H outperforms 96.88% of its industry peers.
C5H's Profit Margin has improved in the last couple of years.
The Operating Margin of C5H (16.87%) is better than 96.88% of its industry peers.
In the last couple of years the Operating Margin of C5H has grown nicely.
C5H has a worse Gross Margin (21.81%) than 75.00% of its industry peers.
C5H's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.87%
PM (TTM) 12.77%
GM 21.81%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
C5H.I Yearly Profit, Operating, Gross MarginsC5H.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so C5H is still creating some value.
C5H has less shares outstanding than it did 1 year ago.
C5H has less shares outstanding than it did 5 years ago.
C5H has a worse debt/assets ratio than last year.
C5H.I Yearly Shares OutstandingC5H.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
C5H.I Yearly Total Debt VS Total AssetsC5H.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

C5H has an Altman-Z score of 4.05. This indicates that C5H is financially healthy and has little risk of bankruptcy at the moment.
C5H has a better Altman-Z score (4.05) than 93.75% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that C5H is not too dependend on debt financing.
C5H has a Debt to Equity ratio (0.45) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 4.05
ROIC/WACC1.36
WACC7.46%
C5H.I Yearly LT Debt VS Equity VS FCFC5H.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

C5H has a Current Ratio of 7.09. This indicates that C5H is financially healthy and has no problem in meeting its short term obligations.
C5H has a better Current ratio (7.09) than 100.00% of its industry peers.
C5H has a Quick Ratio of 1.28. This is a normal value and indicates that C5H is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.28, C5H belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.09
Quick Ratio 1.28
C5H.I Yearly Current Assets VS Current LiabilitesC5H.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

C5H shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.00%.
C5H shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.48% yearly.
C5H shows a decrease in Revenue. In the last year, the revenue decreased by -4.33%.
The Revenue has been growing by 14.59% on average over the past years. This is quite good.
EPS 1Y (TTM)-9%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%-29.5%
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%-22.31%

3.2 Future

C5H is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.22% yearly.
Based on estimates for the next years, C5H will show a small growth in Revenue. The Revenue will grow by 7.42% on average per year.
EPS Next Y15.37%
EPS Next 2Y12.71%
EPS Next 3Y10.22%
EPS Next 5YN/A
Revenue Next Year9.92%
Revenue Next 2Y10.01%
Revenue Next 3Y7.42%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
C5H.I Yearly Revenue VS EstimatesC5H.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
C5H.I Yearly EPS VS EstimatesC5H.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 0.1 0.15 0.2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.81, which indicates a correct valuation of C5H.
Based on the Price/Earnings ratio, C5H is valued a bit cheaper than 75.00% of the companies in the same industry.
C5H is valuated cheaply when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.70, the valuation of C5H can be described as reasonable.
C5H's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. C5H is cheaper than 68.75% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.23. C5H is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.81
Fwd PE 8.7
C5H.I Price Earnings VS Forward Price EarningsC5H.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

C5H's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.91
C5H.I Per share dataC5H.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of C5H may justify a higher PE ratio.
PEG (NY)0.83
PEG (5Y)0.63
EPS Next 2Y12.71%
EPS Next 3Y10.22%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.09%, C5H is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.69, C5H pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, C5H pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.09%

5.2 History

The dividend of C5H is nicely growing with an annual growth rate of 23.30%!
Dividend Growth(5Y)23.3%
Div Incr Years3
Div Non Decr Years3
C5H.I Yearly Dividends per shareC5H.I Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06

5.3 Sustainability

51.93% of the earnings are spent on dividend by C5H. This is a bit on the high side, but may be sustainable.
C5H's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP51.93%
EPS Next 2Y12.71%
EPS Next 3Y10.22%
C5H.I Yearly Income VS Free CF VS DividendC5H.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
C5H.I Dividend Payout.C5H.I Dividend Payout, showing the Payout Ratio.C5H.I Dividend Payout.PayoutRetained Earnings

CAIRN HOMES PLC

DUB:C5H (1/2/2026, 7:00:00 PM)

2.05

-0.03 (-1.44%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)09-03 2025-09-03
Earnings (Next)02-25 2026-02-25/amc
Inst Owners80.17%
Inst Owner ChangeN/A
Ins Owners3.78%
Ins Owner ChangeN/A
Market Cap1.28B
Revenue(TTM)778.20M
Net Income(TTM)99.37M
Analysts83.64
Price Target2.54 (23.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.09%
Yearly Dividend0.07
Dividend Growth(5Y)23.3%
DP51.93%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.92%
PT rev (3m)1.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 12.81
Fwd PE 8.7
P/S 1.65
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB 1.69
EV/EBITDA 11.91
EPS(TTM)0.16
EY7.8%
EPS(NY)0.24
Fwd EY11.49%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.24
BVpS1.22
TBVpS1.21
PEG (NY)0.83
PEG (5Y)0.63
Graham Number2.1
Profitability
Industry RankSector Rank
ROA 7.73%
ROE 13.01%
ROCE 11.85%
ROIC 10.12%
ROICexc 10.54%
ROICexgc 10.58%
OM 16.87%
PM (TTM) 12.77%
GM 21.81%
FCFM N/A
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
ROICexc(3y)11.53%
ROICexc(5y)8.59%
ROICexgc(3y)11.58%
ROICexgc(5y)8.63%
ROCE(3y)13.13%
ROCE(5y)9.75%
ROICexgc growth 3Y32.35%
ROICexgc growth 5Y16.05%
ROICexc growth 3Y32.21%
ROICexc growth 5Y15.96%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
F-Score2
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 2.55
Cap/Depr 127.6%
Cap/Sales 0.45%
Interest Coverage 11.65
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.09
Quick Ratio 1.28
Altman-Z 4.05
F-Score2
WACC7.46%
ROIC/WACC1.36
Cap/Depr(3y)261.68%
Cap/Depr(5y)199.51%
Cap/Sales(3y)0.79%
Cap/Sales(5y)0.56%
Profit Quality(3y)113.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%-29.5%
EPS Next Y15.37%
EPS Next 2Y12.71%
EPS Next 3Y10.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%-22.31%
Revenue Next Year9.92%
Revenue Next 2Y10.01%
Revenue Next 3Y7.42%
Revenue Next 5YN/A
EBIT growth 1Y-9.69%
EBIT growth 3Y36.95%
EBIT growth 5Y17.14%
EBIT Next Year11.7%
EBIT Next 3Y7.53%
EBIT Next 5YN/A
FCF growth 1Y-144.51%
FCF growth 3Y14.39%
FCF growth 5Y5.88%
OCF growth 1Y-137.35%
OCF growth 3Y15.01%
OCF growth 5Y6.31%

CAIRN HOMES PLC / C5H.I FAQ

Can you provide the ChartMill fundamental rating for CAIRN HOMES PLC?

ChartMill assigns a fundamental rating of 6 / 10 to C5H.I.


Can you provide the valuation status for CAIRN HOMES PLC?

ChartMill assigns a valuation rating of 5 / 10 to CAIRN HOMES PLC (C5H.I). This can be considered as Fairly Valued.


What is the profitability of C5H stock?

CAIRN HOMES PLC (C5H.I) has a profitability rating of 8 / 10.


How financially healthy is CAIRN HOMES PLC?

The financial health rating of CAIRN HOMES PLC (C5H.I) is 6 / 10.


What is the earnings growth outlook for CAIRN HOMES PLC?

The Earnings per Share (EPS) of CAIRN HOMES PLC (C5H.I) is expected to grow by 15.37% in the next year.